This inventor holds 7 USPTO granted patents. Top assignees: Iridex Corporation, National University Hospital (Singapore) Pte. Ltd., National University of Singapore. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Singapore, CN (2019)
- Singapore, SG (2015 - 2021)
- Singpaore, SG (2023)
Company Filing History:
7 out of 51 
5 out of 23 
3 out of 851 
Years Active: 2015-2025
Title: Paul T K Chew – Innovator in Ophthalmic Laser Technologies
Introduction
Paul T K Chew is a prominent inventor based in Singapore, renowned for his contributions to the field of ophthalmic laser technologies. With a remarkable portfolio of 7 patents, his innovative work aims to enhance treatments for various eye conditions, particularly glaucoma.
Latest Patents
One of his latest patents focuses on a contact probe for the delivery of laser energy, which incorporates systems, devices, and methods designed for treating a glaucomatous eye. The invention features a hand-holdable device with an elongate member and a contact member, which ensures that pulsed laser energy can be accurately delivered to the pars plana of the eye. This technology allows for the alignment of the contact member with the limbus while maintaining an angular offset of the treatment axis from the optical axis of the eye. The delivered pulsed laser energy does not achieve therapeutic photocoagulation; however, it effectively enhances uveoscleral outflow, leading to sustained reductions in intraocular pressure.
Career Highlights
Throughout his career, Paul T K Chew has been associated with prestigious organizations like Iridex Corporation and the National University Hospital (Singapore) Pte. Ltd. His innovative approach has greatly impacted the landscape of ophthalmic treatments, providing effective solutions for eye care professionals.
Collaborations
In his pursuit of innovation, Paul has collaborated with notable names in the field, including David M Buzawa and Giorgio Dorin. These partnerships have facilitated the development of advanced technologies that continue to shape the treatment of glaucoma and other eye disorders.
Conclusion
With his extensive work in improving ocular health through innovative technologies, Paul T K Chew stands out as a leading inventor in the ophthalmic field. His patented inventions not only demonstrate his dedication to enhancing patient care but also reflect the growing importance of innovative solutions in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile